All posts by: Michael Zand

About Michael Zand

FDA OKs Stem Cell Trial for Spinal Cord Injuries – Drug Discovery & Development

Drug Discovery & DevelopmentThe U.S. Food and Drug Administration (FDA) has authorized the StemCells Inc.’s Investigational New Drug (IND) application for clinical testing of the company’s HuCNS-SC human neural stem cells as a treatment for spinal cord injury. As a first action …StemCells, Inc. Announces Pricing of Public Offering to Raise $16.2 MillionWall Street JournalFDA … Continue reading

2013-10-03 NEWS

World-first Trial for Tendon Repair Using Tendon Stem Cells Published in the … – Sacramento Bee

World-first Trial for Tendon Repair Using Tendon Stem Cells Published in the …Sacramento BeePERTH, Australia, Oct. 2, 2013 — /PRNewswire/ — Regenerative medicine company, Orthocell Limited (Orthocell), today announced the results of its unprecedented and successful clinical trial for the treatment of tendon injuries using its patented stem … …read more   &nbs… Continue reading

2013-10-02 NEWS

Welsh firm announces stem cell logistics joint venture – SelectScience.net (press release)

Welsh firm announces stem cell logistics joint ventureSelectScience.net (press release)Biotec Services International, a leader in clinical trials supply chain management, has announced a joint venture with AwenID, a Swansea University Life Sciences spin-out company, to develop technology that increases efficiency and reduces risk in stem … …read more   &nbs… Continue reading

2013-10-02 NEWS